argenx SE (ARGX.BR)

EUR 575.6

(1.34%)

Long Term Debt Summary of argenx SE

  • argenx SE's latest annual long term debt in 2023 was 15.35 Million EUR , up 70.43% from previous year.
  • argenx SE's latest quarterly long term debt in 2024 Q2 was 28.1 Million EUR , down 0.0% from previous quarter.
  • argenx SE reported annual long term debt of 9 Million USD in 2022, up 13.24% from previous year.
  • argenx SE reported annual long term debt of 7.95 Million USD in 2021, up 28.47% from previous year.
  • argenx SE reported quarterly long term debt of 28.1 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • argenx SE reported quarterly long term debt of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of argenx SE (2023 - 2010)

Historical Annual Long Term Debt of argenx SE (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 15.35 Million EUR 70.43%
2022 9 Million USD 13.24%
2021 7.95 Million USD 28.47%
2020 6.19 Million EUR 21.77%
2019 5.08 Million EUR 0.0%
2018 - EUR 0.0%
2017 - EUR 0.0%
2016 - EUR 0.0%
2015 - EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%
2010 - EUR 0.0%

Peer Long Term Debt Comparison of argenx SE

Name Long Term Debt Long Term Debt Difference
Nicox S.A. 25.15 Million EUR 38.958%
European Medical Solutions 12.71 Million EUR -20.746%
FERMENTALG 14.33 Million EUR -7.086%
BioSenic S.A. 15.57 Million EUR 1.406%
Celyad Oncology SA 902 Thousand EUR -1602.217%
Hyloris Pharmaceuticals SA 344 Thousand EUR -4363.372%
Onward Medical N.V. 16.3 Million EUR 5.838%
Oxurion NV 117 Thousand EUR -13023.077%
PHAXIAM Therapeutics S.A. 7.03 Million EUR -118.407%
Financière de Tubize SA - EUR -Infinity%
UCB SA 2.87 Billion EUR 99.467%